We have also shown that injection of a rat version of this antibody, rMab22A2, reduces bioavailable serum AMH levels in the anovulatory GK rat, a spontaneous model of PCOS that displays all the features of women with the syndrome. This evidence concerns the gene AMH and polycystic ovary syndrome.